Descriptions

The Tumor Necrosis Factor (TNF) Receptor Associated Factor (TRAF) class of intracellular signal transducers is responsible for mediating many of the activation events initiated by TNF receptor (TNFR) and Toll-like/Interleukin-1, 17 and 18 receptor (TIR) families. ​​These receptors can, both directly and indirectly, activate TRAF6 via specific binding of proteins containing TRAF Interacting Motif (TIM) peptides to a groove on the carboxyl-terminal MATH domain.
TRAF6 is autoinhibited by an intramolecular interaction between the RING-Zinc (RZ) region and MATH domain. The interaction renders TRAF6 inactive and structurally closed, as well as incapable of auto-ubiquitination. RING-Zinc fingers region and the MATH domain are targets for ubiquitination. TRAF autoubiquitination in trans is a means of sustaining an open conformation active in downstream signaling.

Autoinhibitory domains (AIDs)

Target domain

70-273 (RZ domain)

Relief mechanism

Partner binding

Assay

Deletion assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

14 structures for Q9Y4K3

Entry ID Method Resolution Chain Position Source
1LB4 X-ray 240 A A 348-504 PDB
1LB5 X-ray 240 A A 347-504 PDB
1LB6 X-ray 180 A A 347-504 PDB
2ECI NMR - A 50-128 PDB
2JMD NMR - A 67-124 PDB
3HCS X-ray 220 A A/B 50-211 PDB
3HCT X-ray 210 A A 50-159 PDB
3HCU X-ray 260 A A/C 50-159 PDB
4Z8M X-ray 295 A A/B 346-504 PDB
5ZUJ X-ray 260 A A 350-501 PDB
6A33 X-ray 210 A A 350-501 PDB
7L3L X-ray 280 A B/D 52-158 PDB
8HZ2 X-ray 260 A A/B 54-210 PDB
AF-Q9Y4K3-F1 Predicted AlphaFoldDB

244 variants for Q9Y4K3

Variant ID(s) Position Change Description Diseaes Association Provenance
CA5949866
rs547082469
11 G>V No ClinGen
1000Genomes
ExAC
gnomAD
rs17852887
CA220595446
12 S>F No ClinGen
Ensembl
rs748986045
CA5949865
12 S>P No ClinGen
ExAC
gnomAD
CA380149131
rs1418472079
13 S>R No ClinGen
gnomAD
CA5949863
rs769322740
17 S>N No ClinGen
ExAC
gnomAD
rs1453088768
CA380149077
18 D>E No ClinGen
TOPMed
CA380149049
rs1314159296
20 C>Y No ClinGen
TOPMed
CA5949861
rs747559755
23 M>V No ClinGen
ExAC
gnomAD
CA220595424
rs765097739
28 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA5949857
rs370057355
29 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949858
rs370057355
29 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1357823611
CA380148914
29 A>V No ClinGen
Ensembl
CA380148903
rs1379813834
30 V>A No ClinGen
gnomAD
rs1418393714
CA380148911
30 V>I No ClinGen
TOPMed
gnomAD
rs1418393714
CA380148909
30 V>L No ClinGen
TOPMed
gnomAD
CA5949856
rs780618300
31 T>I No ClinGen
ExAC
gnomAD
CA380148887
rs1421138534
32 K>E No ClinGen
gnomAD
CA220595406
rs76605445
33 D>A No ClinGen
Ensembl
rs76605445
CA220595404
33 D>G No ClinGen
Ensembl
rs758804620
CA5949855
35 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs750708011
CA5949854
36 V>M No ClinGen
ExAC
gnomAD
CA380148799
rs1259355702
38 G>R No ClinGen
gnomAD
CA5949853
rs779230479
41 S>N No ClinGen
ExAC
gnomAD
rs759328711
CA220595397
42 T>M No ClinGen
TOPMed
gnomAD
rs753791639
CA5949851
43 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA220595386
rs1031359230
44 N>S No ClinGen
TOPMed
CA5949849
rs759449231
45 L>F No ClinGen
ExAC
gnomAD
rs751488547
CA5949848
46 S>A No ClinGen
ExAC
rs1294385877
CA380148698
46 S>F No ClinGen
Ensembl
CA380148669
rs1311497253
49 F>L No ClinGen
gnomAD
CA380148641
rs1373018587
50 M>I No ClinGen
TOPMed
CA5949847
rs766198008
50 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1590642478
CA380148630
51 E>G No ClinGen
Ensembl
rs998647138
CA220595370
52 E>D No ClinGen
TOPMed
rs904321355
CA220595367
53 I>N No ClinGen
gnomAD
rs772870667
CA5949845
58 V>A No ClinGen
ExAC
gnomAD
CA380148536
rs1179758607
58 V>I No ClinGen
gnomAD
rs1353605695
CA380148488
61 D>G No ClinGen
Ensembl
CA380148352
rs1455356924
71 P>A No ClinGen
gnomAD
rs199552714
COSM3769288
CA5949843
83 T>M pancreas [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
rs1564968169
CA380148190
84 P>L No ClinGen
Ensembl
rs1263751287
CA380148119
91 K>R No ClinGen
gnomAD
CA380148101
rs1590642358
94 I>V No ClinGen
Ensembl
CA5949839
rs34320471
95 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA220595329
rs1019670034
97 S>* No ClinGen
TOPMed
CA380148066
rs1325843053
99 R>K No ClinGen
TOPMed
CA380148040
rs1169399583
101 A>S No ClinGen
gnomAD
rs368077395
CA5949820
109 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs774914488
CA380147963
112 L>V No ClinGen
ExAC
gnomAD
rs552722556
CA5949817
116 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5949818
rs771304757
116 Q>K No ClinGen
ExAC
TOPMed
gnomAD
rs1564967420
CA380147914
119 P>R No ClinGen
Ensembl
CA5949814
COSM1268460
rs748164490
121 N>S oesophagus [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs945331121
CA220594203
125 R>C No ClinGen
gnomAD
rs781247915
CA5949813
127 I>V No ClinGen
ExAC
gnomAD
rs1255863441
CA380147846
129 S>C No ClinGen
gnomAD
rs758390119
CA380147838
131 M>L No ClinGen
ExAC
gnomAD
CA5949812
rs758390119
131 M>V No ClinGen
ExAC
gnomAD
CA5949811
rs750341857
133 K>I No ClinGen
ExAC
gnomAD
CA5949810
rs764984865
135 P>A No ClinGen
ExAC
gnomAD
rs757037041
CA5949809
140 L>F No ClinGen
ExAC
gnomAD
CA380147760
rs1448050815
141 H>Q No ClinGen
TOPMed
rs915337241
CA220594191
144 E>K No ClinGen
Ensembl
CA5949786
rs763790387
152 Q>E No ClinGen
ExAC
gnomAD
rs763790387
CA380147513
152 Q>K No ClinGen
ExAC
gnomAD
CA220593597
rs963936751
153 A>T No ClinGen
Ensembl
rs1479680091
CA380147502
154 H>Y No ClinGen
TOPMed
rs184872313
CA5949784
155 C>S No ClinGen
1000Genomes
ExAC
gnomAD
rs767175873
CA5949783
156 E>G No ClinGen
ExAC
gnomAD
CA380147467
rs1293716205
158 A>V No ClinGen
gnomAD
rs759073172
CA5949782
159 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs145863131
CA5949781
160 M>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA220593563
rs950811873
161 D>N No ClinGen
TOPMed
gnomAD
rs1186118901
CA380147435
163 P>L No ClinGen
TOPMed
CA380147436
rs1564966938
163 P>S No ClinGen
Ensembl
CA380147412
rs1429532893
166 Q>R No ClinGen
TOPMed
rs374431321
CA5949778
167 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs577802750
CA220593546
167 R>H No ClinGen
TOPMed
gnomAD
rs75433098
CA220593542
169 F>L No ClinGen
Ensembl
CA220593535
rs74830764
170 Q>P No ClinGen
Ensembl
rs1394703667
CA380147364
173 H>R No ClinGen
gnomAD
rs762066204
CA5949776
174 I>V No ClinGen
ExAC
gnomAD
CA380147342
rs1324774737
176 I>S No ClinGen
gnomAD
rs768746489
CA5949774
176 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs778722636
CA5949772
181 D>A No ClinGen
ExAC
gnomAD
rs777671341
CA5949769
186 Q>H No ClinGen
ExAC
gnomAD
CA220593518
rs202213842
187 V>A No ClinGen
1000Genomes
CA220593513
rs1047107972
188 S>Y No ClinGen
TOPMed
CA380147247
rs1388994498
190 D>V No ClinGen
gnomAD
CA380147242
rs1215343595
191 N>Y No ClinGen
gnomAD
rs752427799
CA5949767
192 C>Y No ClinGen
ExAC
gnomAD
rs780939272
CA5949766
194 A>S No ClinGen
ExAC
gnomAD
rs780939272
CA380147223
194 A>T No ClinGen
ExAC
gnomAD
rs754545305
CA5949765
194 A>V No ClinGen
ExAC
gnomAD
CA380147217
rs1272594739
195 S>P No ClinGen
gnomAD
CA5949763
rs765799965
196 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1466495606
CA380147201
197 A>E No ClinGen
gnomAD
rs763566105
CA5949762
197 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs763566105
CA380147203
197 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs370394325
CA5949747
203 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA220592444
rs146832696
203 I>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949748
rs146832696
203 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1005252014
CA220592445
203 I>V No ClinGen
gnomAD
rs145105758
CA5949746
206 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380146965
rs1434629204
210 L>S No ClinGen
gnomAD
CA380146949
rs1175565773
211 A>V No ClinGen
gnomAD
rs148861693
COSM926727
CA5949744
212 N>S endometrium [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
COSM1507898
rs765675724
CA5949742
219 N>S lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA380146839
rs1325739918
221 I>T No ClinGen
gnomAD
rs200882261
CA5949741
221 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA380146825
rs1210133922
223 I>V No ClinGen
gnomAD
rs754269736
CA5949740
225 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs754269736
CA380146807
225 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA5949720
rs756392662
227 M>I No ClinGen
ExAC
gnomAD
rs752986438
CA5949719
228 P>S No ClinGen
ExAC
gnomAD
rs767573599
CA5949718
233 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA380146043
rs1291857212
234 D>V No ClinGen
gnomAD
CA5949717
rs759661560
235 C>F No ClinGen
ExAC
gnomAD
rs1356662734
CA380146017
236 P>R No ClinGen
gnomAD
CA380146005
rs1365384154
238 A>T No ClinGen
TOPMed
rs1295724464
CA380145981
240 I>V No ClinGen
gnomAD
rs774636689
CA5949716
241 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs377030527
CA5949715
245 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949714
rs376945338
247 F>S No ClinGen
ESP
ExAC
gnomAD
rs1477427444
CA380145893
248 G>D No ClinGen
gnomAD
CA5949713
rs776672755
248 G>R No ClinGen
ExAC
CA380145860
rs1455564718
251 E>K No ClinGen
gnomAD
CA380145850
rs1305709407
252 K>E No ClinGen
TOPMed
rs1375802941
CA380145844
252 K>R No ClinGen
TOPMed
gnomAD
rs775208286
CA5949686
253 M>I No ClinGen
ExAC
gnomAD
rs760658124
CA5949687
253 M>V No ClinGen
ExAC
gnomAD
rs1255316683
CA380145633
259 A>S No ClinGen
gnomAD
CA380145624
rs771879519
260 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA5949685
rs771879519
260 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs759228997
CA5949684
262 L>Q No ClinGen
ExAC
gnomAD
rs1590634108
CA380145522
269 H>N No ClinGen
Ensembl
CA5949683
rs773951368
270 M>I No ClinGen
ExAC
gnomAD
CA220590001
rs963487647
273 L>F No ClinGen
TOPMed
CA380145413
rs1441975568
278 H>D No ClinGen
gnomAD
CA380145409
rs1441975568
278 H>N No ClinGen
gnomAD
CA220589990
rs55840758
279 S>N No ClinGen
Ensembl
rs1397134360
CA380145346
282 V>D No ClinGen
gnomAD
CA5949680
rs376933557
282 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949679
rs376933557
282 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949678
rs748672638
283 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1169635412
CA380145329
283 I>T No ClinGen
gnomAD
CA380145305
rs1173673453
284 P>R No ClinGen
gnomAD
CA5949677
rs781456089
284 P>T No ClinGen
ExAC
gnomAD
rs1158440319
CA380145290
285 D>G No ClinGen
TOPMed
CA5949675
rs751855450
285 D>N No ClinGen
ExAC
gnomAD
CA5949674
rs147645716
286 S>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949673
rs758560289
287 G>E No ClinGen
ExAC
gnomAD
rs900697253
CA220589921
288 Y>C No ClinGen
TOPMed
CA5949672
rs750597806
288 Y>H No ClinGen
ExAC
gnomAD
rs1207985971
COSM3700062
CA5949670
289 I>V liver [Cosmic] No ClinGen
cosmic curated
gnomAD
CA380145197
COSM1507899
rs1279744976
292 V>F lung [Cosmic] No ClinGen
cosmic curated
gnomAD
CA5949668
rs78639425
293 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA220589887
rs776312804
293 R>W No ClinGen
Ensembl
CA380145157
rs1277936375
294 N>H No ClinGen
gnomAD
CA380145081
rs1165511778
298 T>S No ClinGen
Ensembl
CA5949666
rs767244798
299 I>V No ClinGen
ExAC
gnomAD
rs759276140
CA5949665
300 H>Q No ClinGen
ExAC
gnomAD
CA380145025
rs1412886563
301 Q>R No ClinGen
gnomAD
CA5949663
rs770500483
314 R>W No ClinGen
ExAC
gnomAD
rs762588981
CA5949662
321 E>Q No ClinGen
ExAC
gnomAD
rs1157696222
CA380144719
324 S>N No ClinGen
TOPMed
gnomAD
rs1157696222
CA380144717
324 S>T No ClinGen
TOPMed
gnomAD
rs145275891
CA5949660
325 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs145275891
CA5949659
325 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1470296867
CA380144709
325 M>V No ClinGen
TOPMed
gnomAD
rs1184735808
CA380144691
326 Y>C No ClinGen
gnomAD
rs780561325
COSM1230215
CA5949655
332 R>Q large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA5949654
rs535909443
333 T>N No ClinGen
ExAC
gnomAD
CA220589778
rs535909443
333 T>S No ClinGen
ExAC
gnomAD
CA5949652
rs778902552
334 I>V No ClinGen
ExAC
gnomAD
rs1351619329
COSM285912
CA380144598
335 R>* large_intestine endometrium [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1351619329
CA380144600
335 R>G No ClinGen
gnomAD
CA380144574
rs1231164368
337 L>F No ClinGen
gnomAD
CA380144565
rs1354747764
338 E>K No ClinGen
TOPMed
gnomAD
CA380144536
rs1293903033
340 K>E No ClinGen
TOPMed
gnomAD
CA5949650
rs752595856
341 V>I No ClinGen
ExAC
gnomAD
rs1342978071
CA380144511
342 A>P No ClinGen
gnomAD
rs1400964751
CA380144479
344 I>M No ClinGen
TOPMed
gnomAD
CA380144485
rs1440580411
344 I>N No ClinGen
TOPMed
rs147417401
CA5949649
344 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949647
rs751422527
350 N>D No ClinGen
ExAC
gnomAD
CA5949646
rs766148455
350 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA5949645
rs762641979
353 Y>S No ClinGen
ExAC
gnomAD
CA380144294
rs1286505713
358 G>V No ClinGen
gnomAD
rs761330797
CA5949642
359 N>S No ClinGen
ExAC
gnomAD
CA5949641
rs376266610
361 G>R No ClinGen
ExAC
TOPMed
rs747509379
CA5949638
362 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs148751232
CA5949639
362 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380144233
rs1447813072
363 H>Y No ClinGen
gnomAD
rs776049763
CA5949637
364 L>W No ClinGen
ExAC
gnomAD
CA5949635
rs746111041
COSM428952
369 E>K kidney breast [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA380143990
rs1401987236
381 Y>H No ClinGen
TOPMed
CA380143858
rs1564964638
391 M>L No ClinGen
Ensembl
CA380143783
rs1183306064
396 Q>P No ClinGen
Ensembl
rs1394252847
CA380143722
401 Q>R No ClinGen
TOPMed
gnomAD
rs548543739
CA5949628
402 R>C No ClinGen
1000Genomes
ExAC
gnomAD
rs199830912
CA5949627
402 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1417916854
CA380143648
406 Y>C No ClinGen
gnomAD
rs1299539710
CA380143630
407 I>M No ClinGen
gnomAD
rs1475820971
CA380143520
417 E>K No ClinGen
TOPMed
gnomAD
rs1475820971
CA380143518
417 E>Q No ClinGen
TOPMed
gnomAD
rs916447705
CA380143473
420 S>N No ClinGen
TOPMed
gnomAD
rs761368102
CA5949624
420 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs916447705
CA220589614
420 S>T No ClinGen
TOPMed
gnomAD
CA380143455
rs1413660417
422 L>I No ClinGen
TOPMed
rs1223436642
CA380143447
422 L>P No ClinGen
gnomAD
CA380143437
rs1564964595
423 P>S No ClinGen
Ensembl
rs1162144803
CA380143380
427 Q>L No ClinGen
TOPMed
CA5949623
rs776263136
430 I>V No ClinGen
ExAC
gnomAD
CA380143339
rs1343753001
431 R>C No ClinGen
gnomAD
rs200661146
CA5949622
434 I>V No ClinGen
1000Genomes
ExAC
gnomAD
rs749812433
CA220589592
439 E>A No ClinGen
Ensembl
rs1437970764
CA380143240
439 E>Q No ClinGen
Ensembl
rs776102924
COSM1507900
CA5949620
442 V>L lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA380143186
rs1327006408
443 R>K No ClinGen
gnomAD
CA380143101
rs1353116587
449 I>V No ClinGen
gnomAD
CA5949618
rs746183280
452 A>T No ClinGen
ExAC
gnomAD
CA380143032
rs1410994328
454 P>A No ClinGen
gnomAD
CA5949617
rs774438696
455 E>K No ClinGen
ExAC
gnomAD
CA5949615
rs749457723
461 R>Q No ClinGen
ExAC
gnomAD
CA220589540
rs773499691
463 T>A No ClinGen
gnomAD
CA220589535
rs942112506
463 T>I No ClinGen
TOPMed
CA380142906
rs1479576702
465 P>A No ClinGen
gnomAD
rs1378303413
COSM73056
CA380142894
466 R>W ovary [Cosmic] No ClinGen
cosmic curated
TOPMed
rs746978261
CA5949612
482 L>I No ClinGen
ExAC
TOPMed
gnomAD
rs779910368
CA380141698
492 T>I No ClinGen
ExAC
gnomAD
rs779910368
CA5949611
492 T>K No ClinGen
ExAC
gnomAD
CA380141651
rs1249361694
496 R>H No ClinGen
Ensembl
CA5949607
rs756987677
502 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA380141526
rs1211229906
505 M>I No ClinGen
TOPMed
rs753514303
CA5949606
505 M>V No ClinGen
ExAC
gnomAD
CA380141515
rs1434112138
506 G>D No ClinGen
gnomAD
rs58304191
CA5949605
507 S>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA220589483
rs950725856
518 T>S No ClinGen
TOPMed
gnomAD
CA5949602
rs138175660
519 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5949603
rs372550520
519 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1030321317
CA220589441
521 G>R No ClinGen
TOPMed
CA5949601
rs759952168
522 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA5949600
rs774832063
523 V>Q No ClinGen
ExAC
gnomAD

No associated diseases with Q9Y4K3

8 regional properties for Q9Y4K3

Type Name Position InterPro Accession
domain Zinc finger, TRAF-type 151 - 192 IPR001293-1
domain Zinc finger, TRAF-type 204 - 261 IPR001293-2
domain Zinc finger, RING-type 70 - 109 IPR001841
domain MATH/TRAF domain 350 - 499 IPR002083
conserved_site Zinc finger, RING-type, conserved site 85 - 94 IPR017907
domain TNF receptor-associated factor 6, C3HC3D-type RING zinc finger 67 - 124 IPR027139
domain TNF receptor-associated factor 6, MATH domain 351 - 500 IPR037309
domain TNF receptor-associated factor 6, zinc finger 2 157 - 183 IPR041310

Functions

Description
EC Number 2.3.2.27 Aminoacyltransferases
Subcellular Localization
  • Cytoplasm
  • Cytoplasm, cell cortex
  • Nucleus
  • Lipid droplet
  • Found in the nuclei of some aggressive B-cell lymphoma cell lines as well as in the nuclei of both resting and activated T- and B-lymphocytes
  • Found in punctate nuclear body protein complexes
  • Ubiquitination may occur in the cytoplasm and sumoylation in the nucleus
  • RSAD2/viperin recruits it to the lipid droplet (By similarity)
PANTHER Family PTHR10131 TNF RECEPTOR ASSOCIATED FACTOR
PANTHER Subfamily PTHR10131:SF131 TNF RECEPTOR-ASSOCIATED FACTOR 6
PANTHER Protein Class scaffold/adaptor protein
PANTHER Pathway Category CCKR signaling map
TRAF6
p38 MAPK pathway
TRAF6
Toll receptor signaling pathway
TRAF6

11 GO annotations of cellular component

Name Definition
CD40 receptor complex A protein complex that contains at least CD40 (a cell surface receptor of the tumour necrosis factor receptor (TNFR) superfamily), and other signaling molecules.
cell cortex The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic side of plasma membrane The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
endosome membrane The lipid bilayer surrounding an endosome.
lipid droplet An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

14 GO annotations of molecular function

Name Definition
histone deacetylase binding Binding to histone deacetylase.
identical protein binding Binding to an identical protein or proteins.
mitogen-activated protein kinase kinase kinase binding Binding to a mitogen-activated protein kinase kinase kinase, a protein that can phosphorylate a MAP kinase kinase.
protein kinase B binding Binding to protein kinase B, an intracellular kinase that is important in regulating glucose metabolism.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
protein N-terminus binding Binding to a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
thioesterase binding Binding to a thioesterase.
tumor necrosis factor receptor binding Binding to a tumor necrosis factor receptor.
tumor necrosis factor receptor superfamily binding Binding to a member of the tumor necrosis factor receptor superfamily.
ubiquitin conjugating enzyme binding Binding to a ubiquitin conjugating enzyme, any of the E2 proteins.
ubiquitin protein ligase activity Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.
ubiquitin-protein transferase activity Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
zinc ion binding Binding to a zinc ion (Zn).

50 GO annotations of biological process

Name Definition
activation of NF-kappaB-inducing kinase activity The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues.
activation of protein kinase activity Any process that initiates the activity of an inactive protein kinase.
antigen processing and presentation of exogenous peptide antigen via MHC class II The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
bone resorption The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.
cell development The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
cellular response to cytokine stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
cellular response to DNA damage stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
cellular response to lipopolysaccharide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
cytoplasmic pattern recognition receptor signaling pathway The series of molecular signals initiated by a ligand binding to a cytoplasmic pattern recognition receptor (PRR). PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species.
Fc-epsilon receptor signaling pathway The series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.
I-kappaB kinase/NF-kappaB signaling The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
in utero embryonic development The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
interleukin-1-mediated signaling pathway The series of molecular signals initiated by interleukin-1 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
interleukin-17-mediated signaling pathway The series of molecular signals initiated by interleukin-17 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
MyD88-dependent toll-like receptor signaling pathway A toll-like receptor signaling pathway in which the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response.
myeloid dendritic cell differentiation The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
negative regulation of transcription, DNA-templated Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
neural tube closure The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
odontogenesis of dentin-containing tooth The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
ossification The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
osteoclast differentiation The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
positive regulation of DNA-binding transcription factor activity Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
positive regulation of I-kappaB kinase/NF-kappaB signaling Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
positive regulation of interleukin-12 production Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
positive regulation of interleukin-2 production Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.
positive regulation of interleukin-6 production Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
positive regulation of JNK cascade Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
positive regulation of JUN kinase activity Any process that activates or increases the frequency, rate or extent of JUN kinase activity.
positive regulation of leukocyte adhesion to vascular endothelial cell Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.
positive regulation of lipopolysaccharide-mediated signaling pathway Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.
positive regulation of NF-kappaB transcription factor activity Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
positive regulation of NIK/NF-kappaB signaling Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
positive regulation of osteoclast differentiation Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
positive regulation of protein ubiquitination Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
positive regulation of T cell cytokine production Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
positive regulation of T cell proliferation Any process that activates or increases the rate or extent of T cell proliferation.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
positive regulation of transcription regulatory region DNA binding Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
protein autoubiquitination The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink.
protein K63-linked ubiquitination A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair.
protein polyubiquitination Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.
regulation of I-kappaB kinase/NF-kappaB signaling Any process that modulates I-kappaB kinase/NF-kappaB signaling.
regulation of immunoglobulin production Any process that modulates the frequency, rate, or extent of immunoglobulin production.
response to interleukin-1 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
stimulatory C-type lectin receptor signaling pathway The series of molecular signals initiated by the binding of C-type lectin to its receptor on the surface of a target cell, and resulting in cellular activation.
T cell receptor signaling pathway The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
T-helper 1 type immune response An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin.
tumor necrosis factor-mediated signaling pathway The series of molecular signals initiated by tumor necrosis factor binding to its receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3ZCC3 TRAF6 TNF receptor-associated factor 6 Bos taurus (Bovine) SS
P70196 Traf6 TNF receptor-associated factor 6 Mus musculus (Mouse) SS
A7XUJ6 TRAF6 TNF receptor-associated factor 6 Sus scrofa (Pig) SS
B5DF45 Traf6 TNF receptor-associated factor 6 Rattus norvegicus (Rat) SS
B6CJY5 TRAF6 TNF receptor-associated factor 6 Macaca mulatta (Rhesus macaque) SS
Q28DL4 traf6 TNF receptor-associated factor 6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) SS
Q6IWL4 traf6 TNF receptor-associated factor 6 Danio rerio (Zebrafish) (Brachydanio rerio) SS
10 20 30 40 50 60
MSLLNCENSC GSSQSESDCC VAMASSCSAV TKDDSVGGTA STGNLSSSFM EEIQGYDVEF
70 80 90 100 110 120
DPPLESKYEC PICLMALREA VQTPCGHRFC KACIIKSIRD AGHKCPVDNE ILLENQLFPD
130 140 150 160 170 180
NFAKREILSL MVKCPNEGCL HKMELRHLED HQAHCEFALM DCPQCQRPFQ KFHINIHILK
190 200 210 220 230 240
DCPRRQVSCD NCAASMAFED KEIHDQNCPL ANVICEYCNT ILIREQMPNH YDLDCPTAPI
250 260 270 280 290 300
PCTFSTFGCH EKMQRNHLAR HLQENTQSHM RMLAQAVHSL SVIPDSGYIS EVRNFQETIH
310 320 330 340 350 360
QLEGRLVRQD HQIRELTAKM ETQSMYVSEL KRTIRTLEDK VAEIEAQQCN GIYIWKIGNF
370 380 390 400 410 420
GMHLKCQEEE KPVVIHSPGF YTGKPGYKLC MRLHLQLPTA QRCANYISLF VHTMQGEYDS
430 440 450 460 470 480
HLPWPFQGTI RLTILDQSEA PVRQNHEEIM DAKPELLAFQ RPTIPRNPKG FGYVTFMHLE
490 500 510 520
ALRQRTFIKD DTLLVRCEVS TRFDMGSLRR EGFQPRSTDA GV